Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



A Metabolic Mechanism of Action of Antiischemic Agents

Institution: University of California, Los Angeles
Investigator(s): Freny Mody, M.D.
Award Cycle: 1993 (Cycle 2) Grant #: 2KT-0049 Award: $225,000
Subject Area: Cardiovascular Disease
Award Type: New Investigator Awards
Abstracts
Publications

A novel metabolically active antianginal agent (trimetazidine) enhances PET measured glucose utilization
Periodical: Journal of Clinical Nuclear Medicine Index Medicus:
Authors: Mody FV, Coyle KB, Hansen HW, et al ABS
Yr: 1995 Vol: 20 Nbr: 9 Abs: Pg: 860

A novel metabolically active antianginal agent (trimetazidine) enhances PET measured glucose utilization
Periodical: Journal of Clinical Nuclear Medicine Index Medicus:
Authors: Mody FV, Coyle KB, Hansen HW, et al ABS
Yr: 1995 Vol: 20 Nbr: 9 Abs: Pg: 860